To update the National Action Plan for Adverse Drug Event Prevention to consider advances in pharmacogenomic research and testing, to improve electronic health records for pharmacogenomic information, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill expands a reporting req, compliance mandate provision: 3. National Action Plan for Adverse Drug Event Prevention, expands a appropriation, reporting req, compliance mandate provision: 4. Adverse drug event and pharmacogenomic testing education for health care professionals The Secretary shall issue guidance for health care, and expands a appropriation, reporting req, compliance mandate provision: 5. It relies on reporting requirements, compliance mandates, and appropriations. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Expands a reporting req, compliance mandate provision: 3. National Action Plan for Adverse Drug Event Prevention.
- Expands a appropriation, reporting req, compliance mandate provision: 4. Adverse drug event and pharmacogenomic testing education for health care professionals The Secretary shall issue guidance for health care...
- Expands a appropriation, reporting req, compliance mandate provision: 5.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill expands a reporting req, compliance mandate provision: 3. National Action Plan for Adverse Drug Event Prevention, expands a appropriation, reporting req, compliance mandate provision: 4. Adverse drug event and pharmacogenomic testing education for health care professionals The Secretary shall issue guidance for health care, and expands a appropriation, reporting req, compliance mandate provision: 5.
Key Policy Areas
Healthcare
Primary Purpose
The bill expands a reporting req, compliance mandate provision: 3. National Action Plan for Adverse Drug Event Prevention, expands a appropriation, reporting req, compliance mandate provision: 4. Adverse drug event and pharmacogenomic testing education for health care professionals The Secretary shall issue guidance for health care, and expands a appropriation, reporting req, compliance mandate provision: 5.
Policy Domains
Sponsors
Legislative Progress
IntroducedMr. Swalwell (for himself and Mr. Crenshaw) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology